Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

10.0%

77 terminated/withdrawn out of 769 trials

Success Rate

89.3%

+2.8% vs industry average

Late-Stage Pipeline

33%

256 trials in Phase 3/4

Results Transparency

60%

386 of 646 completed trials have results

Key Signals

18 recruiting386 with results48 terminated29 withdrawn

Enrollment Performance

Analytics

N/A
363(51.9%)
Phase 4
146(20.9%)
Phase 3
110(15.7%)
Phase 2
64(9.1%)
Phase 1
17(2.4%)
700Total
N/A(363)
Phase 4(146)
Phase 3(110)
Phase 2(64)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (769)

Showing 20 of 769 trials
NCT06784661Phase 4Completed

Immediate Effects of Lipid-Based and Non-Lipid Artificial Tears on Corneal Aberrations

Role: collaborator

NCT07531043Phase 3Not Yet Recruiting

An Evaluation of the Efficacy and Safety of FID 123472 Ophthalmic Solution for the Reduction of Ocular Redness

Role: lead

NCT07325240Phase 4Recruiting

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

Role: collaborator

NCT07451184Phase 4Recruiting

Comparison of Ocular Lubricants in People With Symptoms of Dry Eye

Role: collaborator

NCT06763731Phase 4Recruiting

Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

Role: collaborator

NCT07540884Not ApplicableNot Yet Recruiting

Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops

Role: lead

NCT07082816Phase 3Completed

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

Role: lead

NCT07161635Not ApplicableActive Not Recruiting

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

Role: lead

NCT07036835Not ApplicableActive Not Recruiting

Clinical Investigation of a Femtosecond Laser for Corneal Flap Creation

Role: lead

NCT07502456Not ApplicableNot Yet Recruiting

Clareon TruPlus Single-Arm Study

Role: lead

NCT07158177Not ApplicableRecruiting

Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity

Role: collaborator

NCT06544694Phase 3Completed

A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

Role: lead

NCT07243275Phase 4Recruiting

SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

Role: collaborator

NCT07303920Not ApplicableRecruiting

Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day

Role: collaborator

NCT07147192Not ApplicableRecruiting

Feasibility Study of an Accommodating IOL Design

Role: lead

NCT06166901Not ApplicableCompleted

Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)

Role: lead

NCT07484191Not ApplicableNot Yet Recruiting

Contralateral Claims Study of Clareon Vivity Pro

Role: lead

NCT07475832Completed

Comparison of Two Biometers in Dense Cataracts

Role: collaborator

NCT06660290Phase 3Completed

A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes

Role: lead

NCT07238699Not ApplicableRecruiting

An Evaluation of the Safety and Tolerability of Ocular Lubricants

Role: lead